Log In
Print
BCIQ
Print
Print this Print this
 

NitroMist (Nitroglycerin lingual spray)

  Manage Alerts
Collapse Summary General Information
Company NovaDel Pharma Inc.
DescriptionNitroglycerin lingual spray
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAngina
Indication DetailsTreat and prevent angina; Treat angina pectoris; Treat angina pectoris due to coronary artery disease (CAD)
Regulatory Designation

Partner

Akrimax Pharmaceuticals LLC; Apricus Biosciences Inc.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$4.0M

$3.0M

$3.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today